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mean square residual (RMS) from the linear regression analysis; RMS quantities the 
deviation of the RR interval from a pure linear change over the 30 sec period. PE was 
defined as the difference in the 30 sec average RR intervals without (day 1) and with 
(day 2) atropine. Results: RMS dramatically increases after I minute of recovery. P 
blockade attenuates the increase in RMS. Day 2 RMS was less than day 1 RMS for all 
time pedods (p<0.03). There was a correlation between day 1 RMS and PE (R2 = 0.63, 
p< 0.0001) Conclusion: RMS is a new measure of HRV that is related to recovery of PE 
after Ex. RMS may help differentiate whether the recently demonstrated prognostic sig- 
nificance of HR recovery after Ex testing is due to P recovery or sympathetic withdrawal, 
both of which decrease HR. If P recovery is more important, RMS may provide better dsk 
stratification than HR recovery. 
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1116-118 Ef fects  of  Nesir i t ide and Dobutamine on Heart Rate 
Variabi l i ty in Patients With Decompensated Heart 
Failure 
Doren Aronson, Dadene P. Horton, Andrew J. Burger, Rambam Medical Center, Haifa, 
Israel, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 
INTRODUCTION: Congestive heart failure (CHF) is characterized by sympathetic over- 
activity and parasympathetic withdrawal. Clinical trials in patients (pts) with decompen- 
sated CHF have shown that nesiritide (brain natriuretic peptide) is associated with 
beneficial hemodynamic effects and symptomatic improvement. Recent studies suggest 
that nesiritide exerts a favorable effect on autonomic dysfunction in CHF. We compared 
the effect of nesirifide and dobutamine (Dob) on heart rate variability (HRV) in decom- 
pensated CHF. 
METHODS: We studied 185 pts admitted for decompensated CHF requiring intravenous 
vasoactive therapy. Baseline 24-h Holters were obtained prior to initiation of the study 
drugs (nesiritide or Dob) and continued for an additional 24-h after initiation of therapy. 
The study population was divided into 2 groups: highly depressed HRV (SDNN < 50 ms) 
and moderately depressed HRV (SDNN = 50-100 ms). HRV time domain indices were 
compared from baseline and treatment Holter recordings. 
RESULTS: In the Dob group, pts with moderately depressed HRV at baseline (n = 20) 
displayed a reduction in indices of total variability such as SDNN (82 ± 4 to 71 ± 4 ms, p 
= 0.01) and SDANN5 (69 ± 3 to 60 ± 4 ms, p = 0.01). Indices of parasympathetic modu- 
lation, pNN50 (7.2 ± 1.5 to 6,6 ± 1.7 %, p = 0.04) and RMSSD (29 ± 4 to 27 ± 4 ms, p = 
0.05), also decreased. With severely depressed HRV (n = 38), no significant changes 
occurred with Dob in indices of overall HRV or parasympathetic modulation. However, in 
the nesiritide group, pts with severely depressed HRV (n = 75) displayed a significant 
increase in SDNN (35 ± 1 to 40 ± 2 ms, p = 0.002), SDANN5 (30 ± 1 to 34 ± 1 ms, p = 
0.02), and RMSSD (13 ± 1 to 15 ± 3 ms, p = 0.01). No significant changes occurred in 
HRV indices with moderately depressed HRV at baseline (n = 53). 
CONCLUSION: In pts with relatively preserved HRV, Dob reduces overall variability and 
parasympathetic modulation. With severely depressed HRV, the effect of Dob on HRV is 
minor, presumably clue to ~,-adrenergic receptor down-regulation or saturation. In con- 
trast, nesiritide improves indices of overall HRV and parasympathetic modulation in pts 
with severely depressed HRV and has no adverse effect on pts with relatively preserved 
HRV. 
1118-119 Altered Fractal Behavior and Heart Rate Var iabi l i ty  in 
Daily Life in Neurally Mediated Syncope 
Bonpei Takase, Haruhiko Hosaka. Yoshihiro Matsushima, Takashi Akima, Syuuichi 
Katsushika, Toshihiko Nishioka, Fumitaka Ohsuzu, Akira Kurita, National Defense 
Medical College, Tokorczawa, Japan, Serf Defense Forces Central Hospital, Tokyo, 
Japan. 
Background: The fractal dimension is an index to the complexity of cardiovascular con- 
trol system and autonomic function is important in the pathogenesis of neurally mediated 
syncope (NMS), However, it is still not fully understood if the derangement of the auto- 
nomic nervous system exists in NMS in daily life. Methods: Thus, we performed 24-hour 
ECG monitoring (AECG) and measured traditional heart rate variability indices (HRV) 
along with long fractal scaling exponent (b) in 36 pts (NMS, 24±3 y/o) with NMS diag- 
nosed by heed-up tilt testing (HUT, 807 tilt) and 11 age-matched normal controls (NL). 
AECG was performed within 48 hours before HUT procedure. For HRV, SDANN, SD, 
rMSSD, pNN50, low frequency (0.04-0.15Hz, LF) and high frequency (0.15-0.40 Hz, HF) 
were measured. All measurements were analyzed in three different periods such as total 
24-hour, awake (09:00-15:00) and sleep (00:00-06:00) phases. The ratio of each mea- 
surements in awake over sleep phase (A/S ratio) was also calculated, Results: Several 
24-hour HRV showed significantly higher values in NMS than those in NL (SD, 91±32 vs 
65±11 ms; rMSSD, 60±31 vs 38±11 ms; pNN50, 30±17 vs 14±7%; LF, 35±15 vs 26¢5 
ms; HF, 27±11 vs 14±7 ms; p<0.05) while 24-hour b was not different (0.95±0.13 vs 
0.95±0.14). In contrast, although NS ratio of any HRV showed no differences,/US ratio 
of b revealed significantly higher value in NMS than in NL (1,7±0.49 vs 1.2i-0.t5, 
p<0.05). The awake and sleep values of b in NMS were also significantly different from 
those in NL, Conclusion; Overall autonomic activity in daily life is exaggerated in NMS. 
Since in most of the time pts are upright during awake and are supine during sleep 
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phase, the significant differences between awake and sleep values of b, and abnormal A/ 
S ratio of b suggest that deteriorated fractat behavior exits in NMS. These findings may 
be associated with the mechanisms of orthostatic intolerance in NMS. 
1116-120 Right Atrial Size May Be a Primary Determinant of Atrial 
Conduction Time of the Sinus Node Impulse 
Susette K. Therkelsen. Bjoem A. Groenning, Uldk Dixen, Gorm B. Jensen, Department 
of Cardiology, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark, 
Danish Research Center of Magnetic Resonance, Copenhagen University Hospital 
Hvidovre, Denmark. 
Background: Prolonged signal-averaged p-wave duration (SAPD) measured by a sig- 
nal-averaged ECG is thought to represent a delay in the intra-atrial conduction of the 
electrical impulse. Prolonged SAPD is a prognostic manker of development of atrial fibril- 
lation (AF). In addition, atrial dilatation in patients with previous AF has been associated 
with dsk of relapse of AF. However, the relation between duration of atrial conduction of 
the electrical impulse and atrial dimensions is not clear. Our aim was to evaluate the cor- 
relation between atdal dimensions measured by magnetic resonance imaging (MRI) and 
the intra-atdal conduction time measured by SAPD. 
Methods: In 7 subjects with no history of cardiac disease, we measured the total filtered 
SAPD. Atrial dimensions were evaluated by cinematographic braathhold MRI scans. 
Results: Right atrial (RA) diastolic volume index (mean+SD=77:P21ml/m2; r=0.83, 
p=0.02), systolic volume index (49~17ml/m2; r=0.76, p=0.05) and stroke volume index 
(29-Z6.7ml/m2; r=0.77, p=0.04) were positively associated with SAPD (135±10.6ms). Left 
atrial (LA) diastolic (64:t:7.1 ml/m 2) and systolic (39~7.3ml/m 2) volume indices and stroke 
volume index (24+1.0ml/m 2) were completely unrelated to SAPD. The combined RA and 
LA diastolic (141.+.21.6ml/m2; r=O.80, p=0.03) and systolic (87.8+17.0ml/m2; r=0.70, 
p=0.08) volume indices correlated positively with SAPD, 
Conclusion: Our results suggest that RA size may be a primary determinant of atdal 
conduction time measured by SAPD. 
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826 External and Implantable Defibrillators: 
Clinical Studies 
Monday, March 18, 2002, 2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, Room 254W 
2:00 p.m. 
826-1 New Therapeutic Option for Patients With Time- 
Dependent Risk of Sudden Cardiac Arrest: Application 
of Novel Wearable Cardloverter-Defibrillator 
Arthur M. Feldman, Helmut Klein, Patrick Tchou, The WEARIT & BIROAD Investigators, 
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, Otto Von Guericke 
Universi~ Magdeburg, Germany. 
Background: Outpatient populations with temporary risk for sudden cardiac arrest (SCA), 
such as patients awaiting cardiac transplant, post-myocardial infarction patients (p-MI) or 
post-CABG patients (p-CABG), often rely on emergency medical services (EMS) for 
defibdllation therapy. Success rates for EMS resuscitation are poor. A new therapeutic 
option, the completely automatic (no bystander intervention) wearable cardioverter- 
defibdllator (WD), may provide better protection for these populations. 
Methods: A mulficenter t ial studied the use of WD (WCD~ system, LIFECOR Inc., Pitts- 
burgh). WD provides automatic detection and treatment of ventricular techycardia and 
fibrillation (VTNF) using unique non-stick ECG electrodes and self-gelling therapy elec- 
trodes. WEARIT sub-population: patients on the cardiac transplant list or equivalent in 
cardiac status. WEARIT subjects used WD until transplanted, hospitalized for transplant 
or circulatory assist device, or receiving an active ICD. BIROAD sub-population: patients 
not receiving an ICD who were p-MI or p-CABG and had either VTNF within 48 hours, an 
ejection fraction < .30 or Killip class > II after 72 hours, or syncopal VTNF after 48 hours. 
BIROAD used WD for -4 months. The effectiveness objective was >25% resuscitation 
success with 90% confidence, The safety objective was <2.3% false shocks per patient- 
month with 90% confidence (500 patient-months minimum). 
Results: There were 8 VTNF SCA events in 6 patients (4 BIROAD, 2 WEARIT). 6 were 
successfully treated, 2 were unsuccessful with V'rNF detected but treatment prevented 
by incorrect patient assembly of WD (therapy electrode in pocket backward, gel released 
away from body). A redesign occurred to prevent this from reoccurring. 6 false shock epi- 
sodes occurred in 873 patlent-months. The most frequently repoded adverse event (20) 
was temporary skin rash under electrodes. 285 patients were enrolled over 3 years. Daily 
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use averaged 21 hours for BIROAD and 19.2 hours for WEARIT. 
Conclusion: WD is a safe (<2.3% false shocks per patient-month) and effective (>25% 
effective resuscitation) alternative to EMS for outpatient populations with a temporary risk 
of SCA. 
2:1 5 p.m. 
826-2 Hospital Readmission After Cardloverter Def ibr i l la tor  
Implantation: Single Chamber Versus Dual Chamber 
Devices 
Ahmad AbouI-Karim. Hassir F. Marrouche, Soufian Almahameed, David O. Martin, 
Niranjan Seshedri, Robert A. Schweikert, Walid SeUba, Bruce wilkoff, Patdck Tchou, 
Andrea Natale, The Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Dual chamber cardioverter defibrillators (ICD) have the capability to dis- 
criminate supraventricular from ventdcular arrhythmia and to maintain AV synchrony, 
which may be important for patients with a poor left ventricular function. The purpose of 
this study was to evaluate whether dual chamber ICDs have any advantage over single 
chamber ICDs in reducing number of cardiac re-hospitalization due to either inappropri- 
ate treatment or congestive heart failure. Methods end results: We report outcomes on 
a total of 461 patients (80% men: mean age 61+ 12 years) routinely followed at our insti- 
tution for at least 2 years. The median follw-up in this population was 36 months. Three 
hundred and ninety patients (85%) had single chamber and 71 patients (15%) had dual 
chamber ICD. Logistic regression was used to assess the relation between type of ICD 
end risk of hospitalization. The risk of being hopitalized at least once by admission indi- 
cation is given in the table. In unadjusted analyses as well as analyses that adjusted for 
age, sex, and ejection fraction, there were no statistically significant relationships 
between hospitalization and ICD type (P • 0.20). Conclusion: Cardiac related re-hospi- 
talization is common in patients with ICDs. The implantation of dual chamber ICD did not 
appear to reduce re-hospitalization for inappropriate shocks, device malfunction or heart 
failure. 
Indication for Admission Single Chamber (N=390) DualChamber(N=71) P-value 
Inappropriate Therapy 28 (7%) 7 (10%) 0.4 
Device Malfunction 40 (10%) 6 (8%) 0,67 
Heart Failure 86 (22%) 20 (28%) 0.23 
2:30 p.m. 
826-3 Implantab le  Card iac  Def ibr i l la tor  Use in Patients With 
Arrhythmogenlc Right Ventricular Dysplaaia 
Allison M. Pdtchett, Paul A. Friedman, Win-Kuang Shen, Mayo Clinic Foundation, 
Rochester, Minnesota. 
Background: We sought to define the characteristics and outcomes of patients with 
arrhythmogenic right ventdcular dysplasia (ARVD) who underwent implentable cardiac 
defibrillator (iCD) placement. 
Methods: Ten patients were identified who had an ICD placed for a diagnosis of ARVD. 
A retrospective chart review was performed to characterize the population, outcomes of 
diagnostic testing, and previous therapies. In addition, patients were contacted by phone 
or survey to identify ICD utilization and adjunctive therapies 
Results: Of the 10 patients, ages ranged from 24-64 (ave 44.4 +14.0) years and 70% 
were women. The diagnostic evaluation included RV biopsy in 50% of patients, cine CT 
50%, and MR170%. EP testing results were available for 9 patients showing inducible VT 
in 77.8% (average 2.00 morphologies, all LBBB pattern). Prior to implantation, 4 of 10 
had taken antiarrhythmics. ICD implantation was undertaken for secondary prevention in 
80% (8/10), 40% out-of-hospital cardiac arrest and 40% sustained VT. The other 20% 
had nonsustained VT. At implantation the average DFT was 11.56 J, range 5-24J. The 
average R wave was 7.84 mV, range 3.5-17.1 inV. 50% required lead repositioning dur- 
ing or lead revision shortly after implantation due to inadequate pace/sense thresholds. 
During a mean follow-up of 41.0 months (range 9-90 months), 8 of 10 patients had 
received therapies from the ICD. The initial therapy occurred between 4 days to 51 
months after implantation. Atrial arrhythmias caused inappropriate treatment in only one 
patient. Additional antiarrhythmio therapy was required in 80% of patients. There were no 
deaths, clinical CHF, or transplantation. 
Conclusions: 1) Despite RV abnormalities, this cohort of symptomatic ARVD patients 
underwent successful transvenous Ice placement. 2) Careful follow-up of pace/sense 
parameters is required. 3) There was a high incidence of appropriate device discharges, 
with 80% requiring adjunctive antiarrhythmic therapy. 4) Given the absence of CHF and 
mortality in this cohort, arrhythmia management and sudden death prevention may 
enhance long-term survival. ICD use appears to play an important role in ARVD therapy. 
2:45 p.m. 
826-4 Performance of the Electrogram Vector Timing and 
Correlation Algorithm for Discrimination of Ventrlcular 
Tachycardia From Supraventrlcular Tachycardla in 
Patients With Wide Sinus Rhythm QRS 
Joseph M. Smith. The Contak CD Investigators, Julie A. Thompson, Eric G. Lovett, Mark 
Schwartz, Joseph Bocek, Jaeho Kim, The Cardiovascular Group, Arlington, Virginia, 
Guidant Corporation, SL Paul, Minnesota. 
Background: Morphology based algodthms have been introduced in implantable cardio- 
verter defibrillators (ICDs) to discriminate ventricular tachycardia (V'F) from supraventric- 
ular tachycardia (SVT), however some of these algorithms have difficulty discriminating 
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VT from SVT in patients who have wide QRS during sinus rhythm. Vector Timing and 
Correlation (V'i'C) is a novel algorithm designed to exploit not only the change in shock 
electrogram associated with V'I', but also the change in relative timing of the rate-sensing 
electrogram with respect to overall ventdcular activation. The goal of this study was to 
assess the performance of V'I'C in discriminating SVI" from V'I" in a subset of patients 
likely to pose the greatest difficulty for rhythm discrimination algorithms, ie, those with 
wide sinus QRS complexes in whom the rate sensing electrogram is derived from a 
broad bipole (left and right ventricle), typical of patients receiving resychronizafion ther- 
apy. 
Methods: Spontaneous tachycardia episodes were retrieved from VENTAK CONTAK 
CD ICD patient disks from 33 patients with wide baseline QRS (>120ms) as measured 
on a surface ECG. A segment of normal sinus rhythm from the shock channel electro- 
gram was used to generate a ventricular conduction reference for each patient. Shock 
channel arrhythmia complexes were aligned with the sinus reference by rate channel tim- 
ing and compared using correlation analysis to classify each complex as V'I" or SVI". 
Contextual classification of complexes was used to diagnose the arrhythmia. 
Results: Thirty-nine sustained spontaneous tachycardia episodes (29 VT, 10 SVT) were 
analyzed. The average baseline QRS width of the patients was 157 ± 22 ms. Sixteen 
patients had left bundle branch block, 7 had right bundle branch block, and 10 had non- 
specific intraventricular conduction delay. Analysis results demonstrated 29/29 VT and 9/ 
10 SV'F episodes were correctly diagnosed by VTC. 
Conclusion: In a prospective evaluation, VTC effectively classified spontaneous tachy- 
cardias from ICD patients with wide baseline QRS and rate sensing electrograms derived 
from widely split sensing electrodes. Clinical experience in ICDs equipped with V'I'C is 
expected to be at least similarly reliable. 
3:00 p.m. 
826-5 Randomized Prospective Study of  S ing le  Coi l  Versus 
Dual Coil Defibrillation in Patients With Ventrlcular 
Arry thmlas  Undergoing ICD Imp lantat ion  
Chdstoober A. Rinaldi. Ron D. Simon, Artur Baszko, Donna Elliott, Julian Bostock, 
Jaswinder S. Gill, Guys and St Thomas NHS Trust, London, United Kingdom. 
Background 
ICD implantation is standard therapy for malignant ventdcular arrythmias. The advantage 
of dual and single coil defibrillator leads in the successful conversion of arrythmias is 
unclear. In this study we compared the effectiveness of dual versus single coil defibrilla- 
tion leads. 
Methods and Results 
The study was a prospective, multi-centre, randomised study comparing a dual coil with 
a single coil defibrillation system as part of an Ice using an active pectoral electrode. 
Seventy six patients (64 men and 12 women; age 61 ± 11 years ) were implanted with 
either a dual (Group 1, n=38) or single coil lead system (Group 2, n=39). The patients 
represented a typical ICD cohort: 60 % presented with ischaemic cardiomyopathy as 
their primary cardiac disease, the mean left ventricular ejection fraction was 40.6 ± 15.8 
%. The primary tachyarrhythmia was monomorphic ventricular tachycardia (MVT) in 52.6 
% patients and ventdcular fibrillation in 38.4 %. There was no significant difference in 
terms of P and R wave amplitudes, pacing thresholds and lead impedance at implanta- 
tion and follow up in th(~ two groups. There was similarly no difference in terms of defibril- 
lation thresholds (DFT) at implantation. Patients in Group 1 had an average DFT of 
10.2±5.2J compared to a DFT of 10.3±4.1J in Group 2, p=NS. 
Conclusions 
Our study demonstrates no significant advantage of a dual coil lead system over a single 
coil system in terms of lead values and defibrillation thresholds. This may have important 
bearing on the choice of lead systems when implanting 
3:15 p.m. 
826-6 Implantab le  Def ibr i l la tor  Events  in Pat ients  With 
Hypertrophic Cardiomyopathy: Low Incidence of  
Ventrlcular and High Incidence of Supraventricular 
Events During Intermediate Term Follow-Up 
Andrea M. Russo, Christa Schorr, Jamie Springman, David Callans, Henry Hsia, Bindi 
Shah, Edca Zado, Francis E. Marchlinski, University of Pennsylvania Health System, 
Philadelphia, Pennsylvania. 
Background: Implantable cardioverter defibrillators (ICDs) are often implanted in high risk 
patients (pts) with hypertrophic cardiomyopathy (HCM), even without documented clini- 
cal sustained ventdcular arrhythmias. However, supraventdcular arrhythmias (SVAs) 
may also occur, leading to inappropriate therapy. 
Methods: We examined 21 pts with HCM who underwent ICD implantation at our center 
to determine the frequency of appropriate and inappropriate shocks during follow-up. 
Results: Mean age was 47 +/- 19, LVEF 65 +/- 12%, septal thickness 20 +/- 7 mm, and 
67% had a significant outflow gradient. Symptoms included syncope 9 pts, presyncope 9 
pts, cardiac arrest 2 pts, and none 1 pt. Eleven pts had inducible sustained ventricular 
tachycardia (VT) or ventricular fibrillation (VF). Dual chamber devices were implanted in 
10 pts. Nine pts underwent at least 1 generator replacement. All pts are alive (mean fol- 
low-up 23 +/- 24 months). 
Thirty detections occurred in the VF zone with 24 shocks and 16 aborted shocks. Shocks 
were delivered in 9 pts (43%). Appropriate therapy for monomorphic VT occurred in only 
1 pt (5%), 8 days following initial implant, and this pt initially presented with sustained VT. 
Inappropriate therapy was delivered for SVAs in 6 pts (29%) and artifact in 3 pts (14%). 
The SVA leading to shock therapy was felt to be sinus techycardia in 5 pts and atrial flut- 
ter in 1 pt. The mean number of months to the first sustained event was 30 +/- 33. Two 
pts experienced syncope or presyncope at follow-up, without associated arrhythmias. 
